Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Henry Schein, Inc.

Aesculap Implant Systems, LLC provides solutions for the changing healthcare environment.

Aesculap Implant Systems, LLC

Biotech Dental is a designer and manufacturer of medical devices and digital solutions for dental surgeons, orthodontists, and dental prosthesis laboratories.

Biotech Dental

DMEscripts automates the medical equipment ordering process to help hospitals, providers, and suppliers focus more on patients and less on paperwork.

DMEscripts

Henry Schein provides dental and medical supplies and solutions for healthcare professionals. Self-described as a global provider, it aims to deliver essential resources to improve practice performance and patient care.

Metric
Company Name	Henry Schein, Inc.	Aesculap Implant Systems, LLC	Biotech Dental	DMEscripts
Symbol	HSIC
MSH ID	COM:HENRYSCHEIN	COM:AESCULAPIMPLANTSYSTEMS	COM:BIOTECH-DENTAL	COM:DMESCRIPTS
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Distribution	Medical Devices	Dental Equipment & Supplies	Medical Equipment
Country	US	US	FR	US
Stage
Employee Count	25K
Website	henryschein.com	aesculapimplantsystems.com	biotech-dental.com	dmescripts.com
LinkedIn			biotechdentalusa
Founders

Metric
Market Cap	8.22B
Enterprise Value
Monthly Web Traffic		3.45K
Web Traffic Growth		4.17
Valuation
Raised Capital

Metric
Revenue	12.34B
Revenue (LTM)
Revenue (NTM)
Gross Profit	3.65B
EBITDA	962M
Operating Income	714M
Net Income	416M
EPS	3.18
Diluted EPS	3.16
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.31
Operating Profit Margin	0.05
EBITDA Margin	0.08
Net Profit Margin	0.03
Return on Equity	0.12
Return on Assets	0.04
Return on Capital Employed	0.08

COM:HENRYSCHEIN

Henry Schein

Last Close

73.77

22/11 21:00

Market Cap

8.22B

Beta: -

Volume Today

3.38M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	21.96
P/B Ratio	2.68
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.77
EV Multiple	7.65

Metric
Days Sales Outstanding	45.23
Days Payables Outstanding	39.72
Days Inventory Outstanding	77.61
Operating Cycle	132.72
Cash Conversion Cycle	89.10
Asset Turnover	1.23

Metric
Operating Cash Flow	500M
Free Cash Flow	313M
Cash Flow to Debt	0.27
Operating Cash Flow/Sales	0.06
Free Cash Flow Yield	0.07

Metric
Cash & Equivalents	171M
Accounts Receivable	-327M
Inventory	1.81B
Goodwill	3.88B
Debt to Capitalization	0.42
Debt to Assets	0.18
Current Ratio	1.97
Quick Ratio	1.02

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.00
R&D to Revenue
SG&A to Revenue